GlassScriptPhysician profile
Amanda Oliveira
NPI 1205677945
$1,672.30
in general payments reported to CMS, 2019-2025
14 companies · $891 in 2025
The $891 reported for 2025 was more than what 85% of Family providers received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2024: $781 · 2025: $891.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,469 · Travel and Lodging: $167 · Education: $36.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,469.34 |
| Travel and Lodging | $166.96 |
| Education | $36.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $379.17 | 2024 | Interstim |
| Sumitomo Pharma America, INC. | $310.17 | 2024-2025 | Gemtesa, Orgovyx |
| Argenx US, INC. | $203.99 | 2024-2025 | Vyvgart, Vyvgart Hytrulo |
| Tolmar, INC. | $189.98 | 2024-2025 | Jatenzo, Eligard |
| Bayer Healthcare Pharmaceuticals INC. | $136.73 | 2024-2025 | |
| Urogen Pharma, INC. | $134.79 | 2024-2025 | |
| Janssen Biotech, INC. | $78.89 | 2024 | Erleada |
| Astellas Pharma US INC | $68.05 | 2025 | Xtandi |
| Abbvie INC. | $42.48 | 2025 | |
| Ferring Pharmaceuticals INC. | $36.69 | 2025 | Adstiladrin |
| Endo USA, INC. | $28.00 | 2025 | Xiaflex, Aveed |
| Boston Scientific Corporation | $26.44 | 2025 | Spaceoar System |
| 180 Medical, INC. | $22.96 | 2025 | |
| Teleflex LLC | $13.96 | 2025 | Barrigel |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Amanda Oliveira listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.